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1. Introduction 
Cellulose probably is the most abundant organic compound in the world which mostly 
produced by plants. It is the most structural component in herbal cells and tissues. Cellulose 
is a natural long chain polymer that plays an important role in human food cycle indirectly. 
This polymer has versatile uses in many industries such as veterinary foods, wood and 
paper, fibers and clothes, cosmetic and pharmaceutical industries as excipient. Cellulose has 
very semi-synthetic derivatives which is extensively used in pharmaceutical and cosmetic 
industries. Cellulose ethers and cellulose esters are two main groups of cellulose derivatives 
with different physicochemical and mechanical properties. These polymers are broadly used 
in the formulation of dosage forms and healthcare products. These compounds are playing 
important roles in different types of pharmaceuticals such as extended and delayed release 
coated dosage forms, extended and controlled release matrices, osmotic drug delivery 
systems, bioadhesives and mucoadhesives, compression tablets as compressibility enhancers, 
liquid dosage forms as thickening agents and stabilizers, granules and tablets as binders, 
semisolid preparations as gelling agents and many other applications. These polymeric 
materials have also been used as filler, taste masker, free-flowing agents and pressure 
sensitive adhesives in transdermal patches. Nowadays cellulose and cellulose based 
polymers have gained agreat popularity in pharmaceutical industries and become more and 
more important in this field owing to production of the new derivatives and finding new 
applications for existed compounds by pharmaceutical researchers.  
2. Classification of cellulose-based polymers 
2.1. Cellulose 
Pure cellulose is available in different forms in the market with very different mechanical 
and pharmaceutical properties. The difference between various forms of cellulose is related 
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to the shape, size and degree of crystallinity of their particles (fibrous or agglomerated). 
Microcrystalline cellulose (MCC) is the most known cellulose which extensively used in 
pharmaceutical industries. MCC grades are multifunctional pharmaceutical excipients 
which can be used as compressibility enhancer, binder in wet and dry granulation 
processes, thickener and viscosity builder in liquid dosage forms and free-flowing agents in 
solid dosage forms. Mechanical properties of MCC grades are greatly influenced by their 
particle size and degree of crystallization. In recent years the new grades of MCC are 
prepared with improved pharmaceutical characteristics such as silisified MCC (SMCC) and 
second generation MCC grades or MCC type II (MCC-II). These grades are prepared by co-
processing of cellulose with other substances such as colloidal silicon dioxide or by special 
chemical procedures. Other types of available pure cellulose are powdered cellulose (PC) 
and low crystallinity powdered cellulose (LCPC).  
Regenerated cellulose is one of the other forms of processed cellulose which produced by 
chemical processing on natural cellulose. In the first step, cellulose dissolves in alkali and 
carbon disulfide to make a solution called "viscose". Viscose reconverted to cellulose by 
passing through a bath of dilute sulfuric acid and sodium sulphate. Reconverted cellulose 
passed through several more baths for sulfur removing, bleaching and adding a plasticizer 
(glycerin) to form a transparent film called cellophane. Cellophane has several applications 
in pharmaceutical packaging due to its suitable characteristics such as good compatibility, 
durability, transparency and elasticity.    
2.2. Cellulose ether derivatives 
Cellulose ethers are high molecular weight compounds produced by replacing the hydrogen 
atoms of hydroxyl groups in the anhydroglucose units of cellulose with alkyl or substituted 
alkyl groups. The commercially important properties of cellulose ethers are determined by 
their molecular weights, chemical structure and distribution of the substituent groups, 
degree of substitution and molar substitution (where applicable). These properties generally 
include solubility, viscosity in solution, surface activity, thermoplastic film characteristics 
and stability against biodegradation, heat, hydrolysis and oxidation. Viscosity of cellulose 
ether solutions is directly related with their molecular weights. Examples of mostly used 
cellulose ethers are: Methyl cellulose (MC), Ethyl cellulose (EC), Hydroxyethyl cellulose 
(HEC), Hydroxypropyl cellulose (HPC), hydroxypropylmethyl cellulose (HPMC), 
carboxymethyl cellulose (CMC) and sodium carboxymethyl cellulose (NaCMC).  
2.3. Cellulose ester derivatives 
Cellulose esters are generally water insoluble polymers with good film forming 
characteristics. Cellulose esters are widely used in pharmaceutical controlled release 
preparations such as osmotic and enteric coated drug delivery systems. These polymers are 
often used with cellulose ethers concurrently for preparation of micro-porous delivery 
membranes. Cellulose esters categorized in organic and inorganic groups. Organic cellulose 
esters are more important in pharmaceutical industries. Various types of organic cellulose 
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esters have been used in commercial products or in pharmaceutical investigations such as 
cellulose acetate (CA), cellulose acetate phthalate (CAP), Cellulose acetate butyrate (CAB), 
Cellulose acetate trimelitate (CAT), hydroxupropylmethyl cellulose phthalate (HPMCP) and 
so on (Heinämäki et al., 1994). The most available formulations in market which made by 
these polymers are enteric coated dosage forms which are usually produced applying acid 
resistant polymeric coats containing phthalate derivatives of cellulose esters especially 
cellulose acetate phthalate (Lecomte et al., 2003; Liu & Williams III, 2002). Inorganic 
cellulose esters such as cellulose nitrate and cellulose sulphate are less important than 
organic cellulose esters in pharmaceutical industries. Cellulose nitrate or pyroxylin is a 
transparent compound with good film forming ability but rarely applied alone in 
pharmaceutical formulations due to its very low solubility in currently used pharmaceutical 
solvents as well as their very high flammability. The use of pure cellulose nitrate in drug 
formulations only limited to one topical anti-wart solution named collodion that made with 
4%w/v concentration in diethyl ether/ethanol mixture as solvent. Cellulose nitrate/cellulose 
acetate mixture are also exploited to prepare micro-porous membrane filters used in 
pharmaceutical industries.   
3. Applications of cellulose and its derivatives in pharmaceutical 
industries 
3.1. Application in bioadhesive and mucoadhesive drug delivery systems 
Bioadhesives and mucoadhesives are drug containing polymeric films with ability of 
adhering to biological membranes after combining with moisture or mucus compounds. 
Bioadhesives were developed in mid 1980s as a new idea in drug delivery and nowadays 
they have been accepted as a promising strategies to prolong the residence time and to 
improve specific localization of drug delivery systems on various biological membranes 
(Lehr, 2000; Grabovac et al., 2005; Movassaghian et al., 2011).  
In compared with tablets, these dosage forms have higher patient compliance due to their 
small size and thickness. Other advantage of these drug delivery systems is their potential to 
prolong residence time at the site of drug absorption and thus they can reduce the dosing 
frequency in controlled release drug formulations. These dosage forms can also intensify the 
contact of their drug contents with underlying mucosal barrier and improve the epithelial 
transport of drugs across mucus membranes especially in the case if poorly absorbed drugs 
(Ludwig, 2005; Lehr, 2000). Some special polymers can be used in these formulations with 
epithelial permeability modulation ability by loosening the tight intercellular junctions. 
Some of these polymers also can act as proteolytic enzymes inhibitor in orally used adhesive 
formulations of sensitive drugs (Lehr, 2000).  
Bioadhesives considered as novel drug delivery systems. These  dosage  forms  are 
formulated to use on the skin and mucus membranes of gastrointestinal, ear, nose, eye, 
rectum and vagina. The main excipients of these formulations are adhesive and film-former 
polymer(s). Adhesive polymers are synthetic, semi synthetic or natural macromolecules 
 Cellulose – Medical, Pharmaceutical and Electronic Applications 50 
with capablility of attaching to skin or mucosal surfaces. Very different types of polymers 
have been used as bioadhesive polymers. Synthetic polymers such as acrylic derivatives, 
carbopols and polycarbophil, natural polymers such as carageenan, pectin, acacia and 
alginates and semi-synthetic polymers like chitosan and cellulose derivatives are used in 
bioadhesive formulations (Deshpande et al., 2009; Grabovac et al., 2005). Cellulose 
derivatives especially cellulose ethers are widely used in bioadhesives. There are used in 
various types of these formulations such as buccal, ocular, vaginal, nasal and transdermal 
formulations alone or with combination of other polymers. More recently used cellulose 
ethers in bioadhesives include nonionic cellulose ethers such as ethyl cellulose (EC), 
hydroxyethyl cellulose, hydoxypropyl cellulose (HPC), methyl cellulose (MC), 
carboxymethyl cellulose (CMC) or hydroxylpropylmethyl cellulose (HPMC) and anionic 
ether derivatives like sodium carboxymethyl cellulose (NaCMC). Ability of polymer to take 
up water from mucus and pH of target place are important factors determining the adhesive 
power of polymers. Some bioadhesive polymers such as polyacrylates show very different 
adhesion ability in various pH values thus the selection of adhesive polymer should be 
made based on the type of bioadhesive preparation. One advantage of cellulose ethers such 
as NaCMC and HPC is lesser dependency of adhesion time and adhesion force of them to 
pH of medium in compared with polyacrylate and thiolated bioadhesive polymers 
(Grabovac et al., 2005). Cellulose ethers, alone or their mixtures with other polymers, have 
been studied in oral (Deshpande et al., 2009; Venkatesan et al., 2006), buccal (Perioli et al 
2004), ocular (Ludwig, 2005), vaginal (Karasulu et al., 2004) and transdermal (Sensoy et al., 
2009) bioadhesives. In some studies, other groups of adhesive polymers or polysaccharides 
are used with cellulose ethers to improve their adhesion characteristics such as adhesion 
time and adhesion force. Concurrent  use  of  polyvinyl  pyrrolidone  (PVP),  hydroxypropyl  
beta  cyclodextrin, polycarbophil, carbopol(s), pectin, dextran and mannitol  with HPMC, 
HEC or NaCMC have been reported in the literatures. (Karavas et al., 2006).  
3.2. Application in pharmaceutical coating processes 
Solid  dosage  forms  such as  tablets, pellets, pills, beads, spherules, granules and 
microcapsules are often coated for different reasons such as protection of sensitive drugs 
from humidity, oxygen and all of inappropriate environmental conditions, protection 
against acidic or enzymatic degradation of drugs, odor or taste masking or making site or 
time specific release characteristics in pharmaceuticals to prepare various modified release 
drug delivery systems such as sustained release, delayed release, extended release, 
immediate release, pulsatile release or step-by-step release dosage forms (Barzegar jalali et 
al., 2007; Gafourian et al., 2007). Both ether and ester derivatives of cellulose are widely used 
as coating of solid pharmaceuticals. Cellulose ethers are generally hydrophil and convert to 
hydrogel after exposing to water. Although, some of the cellulose ethers e.g. ethyl cellulose 
are insoluble in water but majority of them such as methyl, hydroxypropyl and 
hydroxylpropylmethyl cellulose are water soluble. Both of soluble and insoluble cellulose 
ethers can absorb water and form a gel. After exposing of these coated dosage forms with 
water, the coating polymers form to hyrogel and gradually dissolve in water until disappear 
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but the insoluble cellulose ether coatings remain as a viscose gel around tablets and drug 
release is performed by diffusion of drug molecules within this layer. These two types of 
dosage forms called dissolution-controlled and diffusion-controlled drug delivery systems, 
respectively. Despite cellulose ethers, the cellulose esters are generally water insoluble or 
water soluble in a distinct pH range. These polymers like cellulose acetate (CA), cellulose 
acetate phthalate (CAP) and cellulose acetate butyrate (CAB) do not form gel in presence of 
water and they are widely used for preparing of pH sensitive and semi-permeable micro-
porous membranes. These membranes are employed for wide variety of controlled release 
coating of pharmaceuticals especially in enteric or osmotic drug delivery devices. These 
polymers are benefited to make different cellulosic membrane filters applied in 
pharmaceutical industries.     
3.3. Application in extended release (ER) solid dosage forms 
3.3.1. In coated extended release formulations 
Extended release pharmaceuticals refer to dosage forms that allow a twofold or greater 
reduction in frequency of the drug administration in comparison with conventional dosage 
forms. These formulations can be made as coated or matrix type. Coated ER formulations 
are generally made with water insoluble polymeric film coating with or without gel-forming 
ability. The dominant mechanism of drug release in coated ERs is diffusion whereas in 
matrix type of ERs, erosion of matrix is the main mechanism of drug release. The most used 
cellulosic polymer in these modified release dosage forms is ethyl cellulose. Ethyl cellulose 
is completely insoluble in water, glycerin and propylene glycol and soluble in some organic 
solvents such as ethanol, methanol, toluene, chloroform and methyl acetate. Aqueous 
dispersions of ethyl cellulose such as Surelease® (Colorcon) or Aquacoat® (FMC 
BioPolymer) or its organic solutions can be used for coating of extended release 
formulations. After ingestion of these formulations, an insoluble viscose gel is forming 
around the tablet which doesn’t allow to drug to freely release from dosage form. Drug 
molecules should pass across this barrier by diffusion mechanism to enter the bulk 
dissolution medium and thusthe release duration is extended much more than the same 
uncoated conventional formulation. Larger solid pharmaceuticals like tablets can be coated 
with rotating pan coaters whereas the smaller types as pills, beads or granules are coated 
with fluidized bed or air-suspension coater equipments. Because of water insolubility of EC, 
it is often used in conjunction with water soluble polymers such as MC and HPMC in 
aqueous coating liquids (Frohoff-Hülsmann et al., 1999a, 1999b). EC solutions in organic 
solvents such as ethanol can be thickened by HPMC or HPC (Rowe, 1986; Larsson et al., 
2010). Water soluble cellulosic polymers with higher amounts can be used as pore former in 
micro-porous types of extended release and enteric systems. Using of plasticizers is 
necessary for achieving acceptable coating of pharmaceuticals by these polymers. EC is 
compatible with commonly used plasticizers such as dibutyl phthalate, diethyl phthalate, 
dicyclohexyl phthalate, butyl phthalyl butyl glycolate, benzyl phthalate, butyl stearate and 
castor oil. Other plasticizers such as triacetin, cholecalciferol and α-tocopherol also have 
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been used in EC film coats (Arwidson et al., 1990; Kangarlou et al., 2008). The molecular 
weights of ECs are in a wide range and different grades of them are existed from 4 to 350 
(Colorcon official website). Concentration of 5%w/v from these EC grades in toluene/ethanol 
mixture at 25°C can produce about 3 to 380 cp viscosity.   
3.3.2. In extended release polymeric matrices 
Matrices are very simple and efficient systems for controlling drug release from dosage 
forms. Production of these systems is less time consuming and no needs to special or 
sophisticated equipments. Majority of ER matrices are made by a simple mixing of drug, 
polymer(s) and filler followed by one or two stage compaction process. Polymeric matrices 
as drug delivery systems are very important in developing of modified release dosage 
forms. In these devices, the drug is dispersed either molecularly or in particulate form 
within a polymeric network. The main types of drug delivery matrices included swellable 
and hydrophilic monolithic, erosion controlled and non-erodible matrices (Roy et al., 2002). 
The use of hydrophilic matrices has become extremely popular in controlling the release rate 
of drugs from solid dosage forms due to their attractiveness in the case of economic and 
process development points of view (Conti et al., 2007). During the last two decades, 
hydrophilic swellable polymers have been widely used for preparation of controlled release 
matrix tablet formulations. Although various types of rate controlling polymers have been 
used in hydrophilic matrices, cellulose derivatives especially cellulose ethers are probably 
the most frequently encountered in pharmaceutical literatures and the most popular 
polymers in formulation of commercially available oral controlled release matrices. They 
good compressibility characteristics so they are easily converted to matrices by direct 
compression technique. In contact with an aqueous liquid, i.e., dissolution medium or 
gastrointestinal fluid, the hydrophilic polymers present in the matrix swell and a viscose 
gelatinous layer formed in outer surface of matrix. This layer controls the drug release from 
matrix. Drug molecules can release out of system by diffusion across this layer. Viscosity of 
the gel layer is a critical rate-controlling factor in drug release rate from matrices. Erosion of 
polymeric matrices also can influence the release of the drug from system. Increasing 
viscosity of the gel, gives rise to increase the resistance against polymer erosion and drug 
diffusion resulting in reduction of the drug release rate. Various types of cellulose 
derivatives have been used in formulation of hydrophilic polymeric matrices such as 
HPMC, NaCMC, CMC, HEC, HPC and EC with different molecular weights (Barzegar-jalali 
et al., 2010; Javadzadeh et al., 2010; adibkia et al., 2011; Asnaashari et al., 2011). Both of 
soluble and insoluble cellulose ethers can be used in hydrophilic polymeric matrices due to 
their hydrophilic nature and ability of them to forming gel in aqueous media. The highest 
swelling power and hydration rate among cellulose ethers is related to HEC (Saša et al., 
2006) but the mostly used cellulose ether is hydrophilic matrices is HPMC due to its 
excellent swelling properties, good compressibility and fast hydration in contact with water 
(Ferrero et al., 2008, 2010; Nerurcar et al., 2005). For achieving the good release 
characteristics, mixtures of various cellulose ethers or mixtures of different grades of a 
distinct polymer with different ratios can be used based on the intended release rate of 
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controlled release system (Chopra et al., 2007). Some specialized hydrophilic matrices can be 
made with cellulose ethers for special purposes for example, HPMC matrices with alkalizing 
buffers like sodium citrate for protection of acid labile drugs have been investigated (Pygall 
et al., 2009).  
3.4. Application in osmotic drug delivery systems 
In recent years, considerable attention has been focused on development of novel drug 
delivery systems (NDDS). Among various NDDS available in the market, oral controlled 
release (CR) systems hold the major market share because of their advantages over others. 
Majority of oral CR systems fall in the category of matrices, reservoirs and osmotic devices. 
Among various types of CR systems, osmotic devices are considered as novel CR systems (J. 
Shokri et al., 2008a). These formulations utilize osmotic pressure as energy source and 
driving force for delivery of drugs. Some physiological factors such as pH, presence of food 
and gastrointestinal motility may affect drug release from conventional CR systems 
(matrices and reservoirs), whereas, drug release from oral osmotic systems is independent 
of these factors to a large extent. A classic osmotic device basically consists of an osmotically 
active core surrounded by a semi-permeable membrane (SPM) and a small orifice drilled 
through SPM using LASER or mechanical drills. In fact, this system is really a coated tablet 
with an aperture which acts as drug delivery port (figure 1). This type of devices is called  
 
Figure 1. Schematic diagram of an EOP osmotic system. 
monolithic or elementary osmotic pumps (EOPs). The more sophisticated osmotic devices 
have bi-layer (push-pull systems) or tri-layer (sandwich osmotic pumps) cores consisted of 
an osmotically active drug layer and polymeric layer(s) in one or two sides. Some of osmotic 
systems called asymmetric membrane or controlled porosity osmotic pumps have not any 
orifice in their SPM (wang et al., 2005). In these devices, water soluble polymers are used in 
their SPM as pore formers. Pore formers dissolve after exposing of dosage form to aqueous 
media and numerous micro pores are created in SPM for drug delivery reason. When an 
osmotic tablet exposed to an aqueous environment, water pumps from outside into the 
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system due to the great osmotic pressure difference between two sides of SPM. Pumping 
of water into the system increases the inner hydrostatic pressure leading the saturated drug 
solution to flow through the small drug delivery orifice or micro pores (in the case of 
asymmetric membrane devices). Because of high difference of osmotic pressure between 
two sides of SPM, the osmotic pressure gradient remain constant and thus, the release rate 
of drug from these devices is almost constant and independent to environmental 
conditions. EOPs are the most commercially important osmotic devices so that more than 
240 patents have been devoted. Procardia XL® and Adalat CR (nifedipine), Acutrium® 
(phenylpropanolamine), Minipress XL® (prazocine) and Volmax® (salbutamol) are 
examples of EOPs available in the market (J. Shokri et al., 2008a; Nokhodchi et al., 2008). 
3.4.1. In SPM formulation of osmotic systems 
As noted earlier, each osmotic delivery system is consisted of two main components 
included osmotically active core and semi-permeable membrane (SPM). Cellulose acetate 
(CA) is the mostly used polymer in formulation of SPM in all types of osmotic drug delivery 
devices. This polymer is the most important cellulose ester derivative with good film 
forming ability and mechanical characteristics for using in osmotic systems. CA is insoluble 
in water in both acidic and alkaline conditions. The CA films are only permeable to small 
molecules such as water while larger molecules like organic drugs can not pass through 
them. Plasticizers are used in SPM composition for improving the flexibility and mechanical 
properties of membrane. Various types of plasticizers have been used in formulation of 
osmotic pharmaceuticals such as castor oil, low and medium molecular weights 
polyethylenglycols (PEGs), sorbitol, glycerin, propylene glycol, triacetine, ethylene glycol 
monoacetate, diethyl phthalate, diethyl tartrate and trimethyl phosphate (J. Shokri et al., 
2008a, 2008b; Prabakaran et al., 2004; Makhija & Vavia, 2003; Liu et al., 2000a, 2000b; 
Okimoto et al., 1999). Generally, the mixture of hydrophilic and hydrophobic plasticizers is 
used for producing the intended drug release characteristics. In controlled porosity osmotic 
pumps (CPOPs), the additional components such as pore formers are needed. The most 
efficient pore formers are hydrophilic polymers with high water solubility properties. Water 
soluble cellulose ether derivatives can be used as pore former in SPM of these devices. Low 
molecular weight grades of these polymers are suitable for this purpose due to their faster 
dissolution rate and lower viscosities. Low molecular weight MCs and HPMCs have been 
used as pore former in CPOP formulations. Central cores are coated with a coating 
formulation containing SPM components such as film former (CA), pore former(s) and 
plasticizer(s) dissolved or dispersed in a suitable liquid base. Acetone/ethanol mixtures are 
generally used as solvent system to dissolve cellulose acetate in coating liquid (J. Shokri et 
al., 2008a; Nokhodchi et al., 2008; M.H. Shokri et al., 2011). In some studies, cellulose acetate 
is used as fine particles suspended in an aqueous medium for coating of osmotic cores (Liu 
et al., 2000b). Ethyl cellulose (EC) and ethylhydroxyl propyl cellulose also have been used as 
SPM of osmotic devices in some studies but permeability of these membranes is lower than 
CA membranes. In these formulations, hydrophilic cellulose ether derivatives such as 
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HPMC have been used for improving SPM permeability (Marucci et al., 2010; Wang et al., 
2005; Hjärtstam et al., 1990).  
3.4.2. In central core of osmotic systems 
Central core of an osmotic pump is generally a simple compressed tablet basically consisted 
of the active drug(s), osmotically active agent(s), hydrophilic polymer(s) and other 
commonly used ingredients such as filler, compressibility enhancer, free flowing agent and 
lubricant. In one compartment devices (EOPs and controlled porosity OP), these polymers 
mixed with other ingredients and compressed to a tablet whereas in two layered (Push-Pull 
systems), or tri layered (Sandwich systems) cores, these polymers compressed in one or two 
separated layer in one or both sides of drug layer (J. Shokri et al., 2008b; Kumaravelrajan et 
al., 2010). These polymers should have high water uptake and swelling capacity. Cellulose 
derivatives play an important role in core formulations of osmotic devices. Water soluble 
cellulose ethers commonly used as core polymers due to their hydrophilicity and good 
swelling properties. Most currently used polymers for this purpose are MC, HEC, HPC and 
HPMC with various molecular weights. After exposing of system to water, water move into 
the system due to great osmotic pressure difference between outer and inner part of device. 
This water is imbibed to polymer(s) and causes swelling of them. Swelling of core 
polymer(s) produce the driving force for ejecting the drug solution from drug release orifice 
with constant rate (J. Shokri et al., 2008a, 2008b; Prabakaran et al., 2004; Makhija & Vavia, 
2003; Liu et al., 2000a, 2000b). Among cellulose ethers, different grades of HPMC have been 
used more than others in core formulation. Microcrystalline cellulose (MCC) has also 
frequently used the core formulations as compressibility enhancer. MCC is one of the most 
compressibility enhancers that widely used in direct compression as well as wet granulation 
techniques for preparing various types of tablets, pellets and pills.   
3.5. Application in enteric coated solid dosage form 
Enteric coated solid dosage forms are the main groups of delayed release drug delivery 
systems which designed for releasing of their drug(s) content in the lower parts of 
gastrointestinal tract such as small intestine and colon. Enteric dosage forms can be 
considered as a type of oral site specific pharmaceuticals that initiate drug release after 
passing from stomach. Enteric oral dosage forms are suitable for formulation of acid-labile 
drugs or drugs with irritancy potential for inner protective layer of stomach such as non-
steroidal anti inflammatory drugs (NSAIDs). The commonly used materials in enteric 
coated formulations are pH-dependent polymers containing carboxylic acid groups. These 
polymers remain un-ionized in low pH conditions like environment of stomach and become 
ionized with increasing of pH toward natural and light alkaline zone similar to the small 
intestine condition (Liu et al., 2011). These polymers also should have the good film forming 
properties to produce smooth coats with good integrity. Various polymers have been used 
for production of enteric coated dosage forms such as Eudragit® polymers and pH-
dependent cellulose derivatives. Cellulose derivatives which commonly used as enteric 
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coating polymers include cellulose acetate phthalate (CAP), cellulose acetate trimelitate 
(CAT), hydroxypropylmethyl cellulose phthalate (HPMCP), carboxymethylethyl cellulose 
(CMEC) and hydroxypropylmethyl cellulose acetate succinate (HPMCAP) (Williams III & 
Liu, 2000). Apart from the main enteric polymer, the type and amount o plasticizer(s) is very 
important for achieving uniform, smooth and resistant enteric films. Some of mostly used 
plasticizers in enteric coated formulations are diethyl phthalate, glyceryl triacetate, glyceryl 
monocaprylate and triethyl citrate (Williams III & Liu, 2000; Gosh et al., 2011). In some 
cases, hydrophilic cellulose ether derivatives especially HPMC are used with enteric 
polymer for improving the film forming and plasticity of main enteric polymer. HPMC is 
also used in enteric coating process as pre-coating or sub-coating polymer due to its very 
good film forming properties and suitable polymer-to-polymer adhesion with enteric 
coating polymers especially with cellulose ester derivatives such as CAP, HPMCP, 
HPMCAS, CMEC and CAT (Williams III & Liu, 2000). Three commercially available enteric 
coating preparations included solid forms of enteric polymers which should be dissolved in 
suitable organic solvent mixture before coating process, ready-to-use organic enteric coating 
solutions and aqueous polymeric dispersions. Aqueous nanodispersions of enteric coating 
polymers such as HPMCP have also been investigated for improving physicochemical and 
mechanical characteristics of coating (Kim et al., 2003). 
3.6. Application as compressibility enhancers 
More than 80 percent of all dosage forms available or administered to man are tablets. The 
main reason of this great popularity is the advantages of tablets over other forms of 
pharmaceuticals. Ease of manufacturing, convenience dosing and greater stability in 
compared with liquid or semisolid dosage forms are some of these advantages. Two 
common ways for tablet manufacturing are compression and molding. Except of a few 
cases, tablets are made by compression technique. The simplest and fastest kind of 
compression is named direct compression method in which the drug and all of other 
excipients are mixed and compressed in one-stage process with proper compression force to 
form tablet. This method commonly used for tabletting of medium to high potency drugs 
where the drug content in them is less than 30% of formulation (Jivari et al., 2000). In the 
other cases with higher amounts of low compactable drugs, dry or wet granulation 
techniques are used for preparing tablets. In dry granulation method, compression of 
ingredients are performed in two or multi-stage process to improve compressibility of the 
ingredients. Slugging and roller compaction techniques used for initial compression of 
powder mixtures before final tabletting process.  
One of the common difficulties in direct compression and dry granulation is low 
compactability of the drug content especially when the drug amount is higher than 30% of 
formulation. In these cases, an efficient compressibility enhancer can help to achieving a 
good tablet with pharmaceutically accepted characteristics. Although, all of the cellulose 
based polymers are good compactable, however special grades of microcrystalline cellulose 
exhibit excellent compatibility. These grades can significantly improve compressibility of 
low compactable powder mixtures so they are widely used as compressibility enhancers in 
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tablet manufacturing by direct compression and dry granulation methods. Various grades of 
MCC have different fundamental properties including their morphology, particle size, 
surface area, porosity and density (Rojas & Kumar, 2011). These physicochemical properties 
poses the different characteristics to them for example, smaller particle size MCC grades 
have good compressibility and poor flowability whereas the larger particle size grades have 
poor compressibility and excellent flowability. Particle size of MCC varies from 20 to 270 
micrometer based on the manufacturer and type of application. MCC is available in three 
public brand names including Avicel® (FMC BioPolymer), VIVAPUR®/EMCOCEL® (JRS 
Pharma) and TABULOSE® (Blanver). Various grades of commercially available Avicel® and 
their particle size are shown in table 1 (Colorcon official website).  
 
brand name Application MCC grade Particle size 
Avicel® Roller compaction DG 45 
Wet granulation PH-101 50 
Direct compression PH-102 100 
HFE-102 100 
Superior compactability PH-105 20 
Superior Flowability PH-102 SCG 150 
PH-200 180 
High Density PH-301 50 
PH-302 100 
Low Humidity PH-103 50 
PH-113 50 
PH-112 100 
PH-200LM 180 
Mouthfeel improvement CE-15 75 
Table 1. Various grenades of Avicel® 
The effects of size, shape and porosity of MCC particles on flowability and compatibility 
have also been investigated by several researchers (Johansson et al., 2001). Various types of 
MCCs are extensively used in direct compression and dry granulation methods especially in 
roller compaction for preparing compressed tablets or pellets (Strydom et al., 2011; 
Bultmann, 2002). Microcrystalline cellulose type II (MCC-II) was recently introduced as new 
pharmaceutical excipients. MCC-II has a fibrous structure with lower compactability than 
MCC grades and suitable for using in rapid disintegrating dosage forms (Rojas et al., 2011; 
Reus-Medina & Kumar, 2006). In recent years, the new methods have been established for 
improving mechanical characteristics of MCCs. One of these innovative methods is 
lubricating or silisfying for improving compactability of low compressible grades of MCCs 
such as MCC-II or large particle size MCC grades. In this method, amorphous silicon 
dioxide (SiO2) is used as companion excipient for co-processing with low compressible 
MCC grades. Cellulose/SiO2 ratio is 98:2 and resulted product is called lubricated or 
silisified microcrystalline cellulose (SMCC). This method can be used for both MCC-I or 
MCC-II for production SMCC-I or SMCC-II (Rojas & Kumar, 2011; Van Veen et al., 2005). 
SMCC-I have excellent  compaction  properties and less  stickiness  to  the  lower  punches 
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over MCC-I or MCC-I/SiO2 physical mixtures (Rojas & Kumar, 2011). SMCC-II has also 
better mechanical properties especially higher compactability than MCC-II without 
detriment if it's self-disintegrating characteristics. SMCC-I grades are commercially 
available under trade name of ProSolv® (JRS Pharma) but SMCC-II is not commercialized 
yet. Apart from MCC, other forms of cellulose are existed such as powdered cellulose (PC) 
and low cristallinity powdered cellulose (LCPC). LCPC and MCC have agglomerated and 
PC has fibrous structure. PC applications in pharmaceutical industries is similar that MCC. 
It is widely used in direct compression formulation and in dry granulation by either 
slugging or roller compaction methods. LCPC is a new direct compression cellulose 
excipient which is prepared by controlled decrystallization and depolymerization of 
cellulose with phosphoric acid (Rojas & Kumar, 2011). LCPC was shown superior tabletting 
properties than direct compression grades of MCC like Avicel®PH-101 (Kothari et al., 2002). 
3.7. Application as gelling agents 
Gels are semisolid systems consisting of dispersions of very small particles or large 
molecules in an aqueous liquid vehicle rendered jellylike by the addition of a gelling agent. 
In recent decades, synthetic and semi-synthetic macromolecules are mostly used as gelling 
agents in pharmaceutical dosage forms. Some of these agents include: carbomers, cellulose 
derivatives and natural gums. Cellulose derivatives such as HPMC and CMC are the most 
popular gelling agents used in drug formulations. These polymers are less sensitive for 
microbial contamination than natural gelling agents such as tragacanth, acacia, sodium 
algininate, agar, pectin and gelatin. Cellulose derivatives generally dissolve better in hot 
water (except MC grades) and their mechanisms of jellification is thermal. For preparing gel, 
powder of these polymers with suitable amount initially dispersed in cold water by using 
mechanical mixture and then, the dispersion is heated to about 60-80°C and gradually 
cooled to normal room temperature to form a gel (except MC grades). The resulted gels 
from these polymers are single-phase gels. Adding of electrolytes in the low concentrations 
increase the viscosity of these gels by salting out mechanism and higher concentrations 
(above 3-4%) can precipitate the polymer and breakup the gel system (Allen, et al., 1995). 
Maximum stability and transparency of the gels prepared by these polymers is about 
neutral range (pH= 7-9) and acidic pHs can precipitate them from gel system. Minimum gel-
forming concentrations of cellulose derivatives are different based on the type and the 
molecular weights of them but the medium range is about 4-6%w/v. The type of cellulose 
derivative in pharmaceutical gels can significantly affect drug release from gel formulations 
(Tas, et al., 2003). These gels also can be used as the base of novel drug delivery systems 
such as liposomal formulations (Gupta, et al., 2012). 
3.8. Application as thickening and stabilizing agents 
Cellulose derivatives are extensively used for thickening of pharmaceutical solutions and 
disperse systems such as emulsions and suspensions (Adibkia et al., 2007a, 2007b). 
Furthermore, these polymers can increase viscosity of non-aqueous pharmaceutical solution 
likes organic-based coating solutions. Viscosity enhancing of drug solutions poses many 
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advantages such as improving consuming controllability and increasing residence time of 
drugs in topical and mucosal solutions which lead to improve bioavailability of topical, 
nasal or ocular preparations (Grove et al., 1990; Adibkia et al., 2007a, 2007b). It has been 
revealed that viscosity enhancement, in some cases, can increase absorption of some poorly-
absorb drugs like insulin from oral dosage forms (Mesiha, M. & Sidhom, M.). Cellulose 
ethers in concentrations lower than minimum gel-forming amounts are used as thickening 
agents or viscosity builder. These polymers play an important role in stabilizing of 
pharmaceutical disperse systems especially in suspensions and coarse emulsions. By 
increasing the viscosity of suspension, based on the stock's equation, the sedimentation rate 
of dispersant decreased and thus, the uniformity of dispersion after shaking of product will 
improve. In the case of emulsions, these polymers can increase the shelf life and their 
resistance against mechanical and thermal shocks. Among cellulose derivatives, cellulose 
ethers especially their higher molecular weight grades are more suitable for using as viscosity 
enhancer and stabilizer for liquid pharmaceutical disperse systems such as suspensions and 
emulsions. There is a direct proportionality between viscosity of cellulose ether solutions and 
molecular weights of them.  
3.9. Application as fillers in solid dosage forms 
Cellulose and related polymers are commonly used in solid dosage forms like tablets and 
capsules as filler. Various forms of cellulose have been used in pharmaceutical preparations 
as multifunctional ingredients thus; they are concerned as precious excipients for 
formulation of solid dosage forms. Cellulose and its derivatives have many advantages in 
using as filler in solid pharmaceuticals such as their compatibility with the most of other 
excipients, pharmacologically inert nature and indigestibility by human gastrointestinal 
enzymes. These polymers do not cause any irritancy potential on stomach and esophagus 
protective mucosa. Various forms of pure cellulose and cellulose ether derivatives can be 
used as filler in these formulations. 
3.10. Application as binders in granulation process 
Binders are the essential components of solid drug formulations made by wet granulation 
process. In wet granulation process, drug substance is combined with other excipients and 
processed with the use of a solvent (aqueous or organic) with subsequent drying and 
milling to produce granules. Cellulose and some derivatives have excellent binding effects 
in wet granulation process. A number of MCC grades such as PH-101 are widely used as 
binder in wet granulation. Other cellulose derivatives such as MC, HPMC and HPC have 
good binding properties in wet granulation. Low substituted cellulose ethers such as low 
substituted HPC (L-HPC) also used as binder in wet granulation process (Desai et al., 2006; 
Wan & Prasad, 1988). Even though, low substituted cellulose ethers have lower water 
solubility compared with normal grades, however they have very good binding efficacy. 
Cross-linked cellulose (CLC) and cross-linked cellulose derivatives such as cross-linked 
NaCMC can be used as excellent binders in pharmaceuticals as well (Chebli & Cartilier, 
1998).  
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3.11. Application as disintegrating agents 
Solid oral dosage forms such as tablets undergo several steps before systemic absorption of 
the drug. Disintegration is the first step immediately after administration of oral dosage 
forms that breakup the dosage forms into the smaller fragments in an aqueous environment. 
Converting of solid dosage forms to smaller fragments, increase the available surface area 
and promote a more rapid release of the drug substances from dosage forms. The earliest 
known disintegrant is Starch. Corn Starch or Potato Starch was recognized as being the 
ingredient in tablet formulations responsible for disintegration as early as 1906. Due to low 
compressibility of starch, pre-gelatinized starch was invented for using as disintegrant. Pre-
gelatinized starch and MCC are two main types of classic disintegrants. In recent years, the 
classic disintegrnts have been gradually replaced with the newer ones called super 
disintegrants. Super disintegrants can acts in lower concentrations than starch and have not 
detriment effect on compressibility and flowability of formulations. Three main groups of 
these excipients are: modified starches like sodium starch glycolate (Primogel®, Explotab®) 
with 4-6% effective concentration, cross-linked polyvinyl pyrrolidones like crospovidone 
(Polyplasdone XL, Kollidon CL) with 2-4% effective concentration and modifies cellulose 
like cross-linked sodium carboxymethyl cellulose or croscarmellose (Ac-Di-SolTM and 
Nymcel) with 2-4% effective concentration in wet granulation process. Modified cellulose 
compounds are very efficient disintegrants and additionally, can accelerate the dissolution 
rate of drugs in aqueous environment (Chebli & Cartilier, 1998).  
3.12. Application as taste masking agents 
There are numerous drugs with unfavorable tastes. The most prevalent unpleasant taste of 
the drugs is bitter taste. Unpleasant-tasting dosage forms leads to lack of patient compliance 
of oral drug preparations. Various tastes are feeling by taste buds on the tongue. Taste buds 
are onion-shaped structures containing between 50 to 100 taste cells. Chemicals from food or 
oral ingested medicine are dissolved by the saliva and enter via the taste pore. They either 
interact with surface proteins known as taste receptors or with pore-like proteins called ion 
channels. These interactions cause electrical changes within the taste cells that trigger them 
to send chemical signals that translate into neurotransmission to the brain. Salt and sour 
responses are of the ion channel type of responses, while sweet and bitter are surface protein 
responses. 
Taste masking is an important consideration in formulation of oral dosage forms especially 
in the case of high dose, poorly tasting drugs. Improving the taste of liquid dosage forms is 
more important because of better sensitivity and faster stimulation of taste receptors by 
liquids in compared than solids. Taste masking in solid dosage forms can be performed by 
coating (in the case of tablets, pellets, pills or coarse granules) or micro-coating (in the case 
of fine granules, powders or microcapsules) of them by a gastro-soluble polymeric coating. 
These coats can prevent from contacting of the drug with taste buds without detriment of 
release characteristics of the drug formulations in gastrointestinal tract. Soluble cellulose 
ether derivatives are suitable for this purpose. These polymers like HPMC, HEC, MC and 
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HPC are completely water soluble and they have very good film forming properties. Some 
grades of MCC also can improve tooth-feel such as Avicel® CE-15. These coats can produce 
additional benefits in drug formulations such as protection of the active ingredients against 
moisture, oxygen of the air and light due to their barrier effects. Masking of the taste in 
liquid dosage forms especially in drug solutions is more sophisticated. In these cases test 
receptor blockers, flavoring agents and viscosity enhancers are simultaneously needed.  
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